Explorer les evidences

0,91 probabilityThe Kaplan-Meier estimate of the probability of being retained in treatment at 12 months was 0.91 in the OSS model.

NigeriaVIH/sidapublié 2025BMC public healthPubMeddocument de 8 observations

15,5 %A weighted HIV prevalence of 15.5% was found among female sex workers in Nigeria.

NigeriaVIH/sidaobservé 2020publié 2025Sexually transmitted infectionsPubMeddocument de 12 observations

16,3 %The prevalence of depression among people living with HIV in two rural secondary health facilities providing antiretroviral therapy services in Southwestern Nigeria was 16.3% between September and December 2020.

Nigeriadépression · VIH/sidaobservé September and December 2020publié 2023AIDS research and therapyPubMeddocument de 8 observations

2 000 NGNThe median maximum amount people living with HIV (PLHIV) on antiretroviral therapy (ART) were willing to pay for premium ART services was NGN2,000 (USD $5.56), with an interquartile range of NGN1,000–NGN3,000.

NigeriaVIH/sidaobservé July and August 2019publié 2023PloS onePubMeddocument de 9 observations

1 250 sexual_contacts1,250 sexual contacts were elicited using the elicitation box model.

NigeriaVIH/sidaobservé Between March 2021 and April 2022publié 2024Global health, science and practicePubMeddocument de 8 observations

53,9 %The prevalence of any ocular disorder among persons living with HIV/AIDS in Osun State, Nigeria was 53.9%.

NigeriaVIH/sidapublié 2026BMC ophthalmologyPubMeddocument de 9 observations

87,5 %87.5% of female sex workers in Kano State, Nigeria, cited desire to know and confirm HIV status as the primary driver for willingness to use HIV services.

NigeriaVIH/sidaobservé 2023publié 2025PloS onePubMeddocument de 7 observations

54,4 %Among HIV-positive pregnant women in Kaduna State, 54.4% had a fair knowledge of antiretroviral therapy.

NigeriaVIH/sidapublié 2025Scientific reportsPubMeddocument de 4 observations

67,3 %The majority of the respondents reported a low level of viral load (67.3%).

NigeriaVIH/sidapublié 2024The Nigerian postgraduate medical journalPubMeddocument de 4 observations

1,28 aORMales among young adults living with HIV in Nigeria were more likely to not be retained in care, with an adjusted odds ratio of 1.28.

NigeriaVIH/sidapublié 2020BMJ global healthPubMeddocument de 7 observations

34,3 %Seventy-nine (34.3%) patients among the 230 participants were living with HIV.

NigeriaVIH/sidapublié 2025West African journal of medicinePubMeddocument de 7 observations

Pre-exposure prophylaxis (PrEP) effectively prevents HIV.

NigeriaVIH/sidapublié 2026AIDS and behaviorPubMeddocument de 6 observations

16 %Among 50 HBsAg-positive samples, 16.0% (8/50) had detectable HDV RNA.

NigeriaHepatitis D · VIH/sidaobservé June 2017 to August 2017publié 2021Virology journalPubMeddocument de 6 observations

28,3 %Among young key populations aged 15–24 years in Nigeria, the most cited barriers to pre-exposure prophylaxis (PrEP) uptake were lack of access (28.3%) and fear of side effects (28.3%) among female sex workers.

NigeriaVIH/sidaobservé 2020publié 2024International journal of STD & AIDSPubMeddocument de 5 observations

30 %Mother-to-child transmission accounts for approximately 30% of the global burden of new paediatric HIV infections.

NigeriaVIH/sidapublié 2024BMC pregnancy and childbirthPubMeddocument de 8 observations

2,98 aORTertiary education was associated with higher odds of prenatal HIV testing among female sex workers in Nigeria (adjusted odds ratio = 2.98).

NigeriaVIH/sidapublié 2024International journal of STD & AIDSPubMeddocument de 12 observations

94,2 %Virologic suppression using a cut-off of less than 400 copies/ml was 94.2% among persons with HIV who initiated ART between January 2016 and September 2022 in Nigeria.

NigeriaVIH/sidapublié 2023AIDS (London, England)PubMeddocument de 4 observations

88,1 %The 6-month retention rate for people living with HIV who accepted the alternative treatment method was 88.1% (n=332).

NigeriaVIH/sidaobservé 6-monthpublié 2019International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 6 observations

1,64 AORLiving with HIV was associated with increased odds of anxiety related to COVID-19 (adjusted odds ratio: 1.64).

NigeriaCOVID-19 · VIH/sidaobservé 2020publié 2022Frontiers in public healthPubMeddocument de 10 observations

2,53 per_1000_person-yearsThe incidence of Kaposi Sarcoma decreased from 2.53 to 1.58 per 1,000 person-years from 2006 to 2009 to 2010–2016.

Nigeriasarcome de Kaposi · VIH/sidaobservé 2006 to 2009publié 2023BMC cancerPubMeddocument de 2 observations

Neither viral load nor blood CD4+ cell count was significantly different between all HbAS versus all HbAA patients.

NigeriaVIH/sidapublié 2022The open AIDS journaleurope_pmcdocument de 3 observations

7,1 %7.1% of the eligible entries received a score of 3 for desirability.

NigeriaVIH/sidaobservé October 2018 to June 2019publié 2020PloS onePubMeddocument de 10 observations

78 %Among Test and Treat patients with a documented viral load, 78% were suppressed (≤400 copies/ml) at 12 months.

NigeriaVIH/sidapublié 2019PloS onePubMeddocument de 7 observations

90 %The self-reported ART adherence level was 90.0% in the north-east of Nigeria.

NigeriaVIH/sidapublié 2022African journal of AIDS research : AJARPubMeddocument de 4 observations

6,3 %Minor PI resistance-associated mutation N88D was identified in 6.3% of CRF02_AG HIV-1 isolates.

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 11 observations